TerminatedNCT03344003

Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq

Studying Hemophilia A

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Octapharma
Principal Investigator
Sri Adapa
Octapharma
Intervention
Wilate or Nuwiq(drug)
Enrollment
14 target
Eligibility
MALE
Timeline
20182020

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03344003 on ClinicalTrials.gov

Other trials for Hemophilia A

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia A

← Back to all trials